The Gallo Center is evaluated annually by a Scientific Advisory Board (SAB) consisting of international leaders in biomedical research. All are members of the National Academy of Sciences. The SAB is responsible for assessing the progress of the research in relation to the overall goals of the Center, making recommendations for future research directions, and providing a comprehensive review of the activities of the Center to the President of the Board of Directors.

Current board members are listed below:

Stanley Prusiner, M.D. (SAB Chairman), Director, Institute for Neurodegenerative Diseases, Professor, Departments of Neurology and Biochemistry, University of California, San Francisco (Nobel Laureate)

R. Adron Harris, Ph.D., M. June and J. Virgil Waggoner Chair in Molecular Biology, Director, Waggoner Center for Alcohol and Addiction Research, The University of Texas, Austin

Stephen F. Heinemann, Ph.D., Professor of Molecular Neurobiology, The Salk Institute for Biological Studies, University of California, San Diego, President, Society for Neuroscience

Eric R. Kandel, M.D., University Professor Depts. of Physiology and Cellular Biophysics, Biochemistry and Molecular Biophysics, and Psychiatry, Columbia University, College of Physicians & Surgeons Psychiatric Institute (Nobel Laureate)

Richard P. Lifton, M.D., Ph.D., Sterling Professor of Genetics and Professor of Medicine and Molecular Biophysics and Biochemistry, Yale University School of Medicine